Abstract
A targeted theranostic delivery system containing two prodrugs with drug tracking and activation monitoring functions was developed for visualizing cancer cell ablation with synergistic anticancer effects.
Original language | English |
---|---|
Pages (from-to) | 11465-11468 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 50 |
Issue number | 78 |
DOIs | |
Publication status | Published - 4 Sept 2014 |
Externally published | Yes |